Invention Grant
- Patent Title: Systems and methods for optimizing insulin dosage
-
Application No.: US15887239Application Date: 2018-02-02
-
Publication No.: US10368745B2Publication Date: 2019-08-06
- Inventor: Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
- Applicant: Roche Diabetes Care, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: ROCHE DIABETES CARE INC
- Current Assignee: ROCHE DIABETES CARE INC
- Current Assignee Address: US IN Indianapolis
- Agency: Dinsmore & Shohl LLP
- Main IPC: A61B5/02
- IPC: A61B5/02 ; A61B5/00 ; A61B5/145 ; G06F19/00 ; G16H10/20 ; G16H20/17 ; G16H80/00 ; G16H10/40 ; A61M31/00 ; A61B5/05 ; C12Q1/00

Abstract:
Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when biomarker sampling parameters fall within the target biomarker range.
Public/Granted literature
- US20180168448A1 SYSTEMS AND METHODS FOR OPTIMIZING INSULIN DOSAGE Public/Granted day:2018-06-21
Information query